{"id":"https://openalex.org/W4403795186","doi":"https://doi.org/10.51847/sndwaqwohx","title":"Evaluating the effects of different doses of fimasartan on methotrexate-induced renal inflammation in rats","display_name":"Evaluating the effects of different doses of fimasartan on methotrexate-induced renal inflammation in rats","publication_year":2024,"publication_date":"2024-01-01","ids":{"openalex":"https://openalex.org/W4403795186","doi":"https://doi.org/10.51847/sndwaqwohx"},"language":"en","primary_location":{"id":"doi:10.51847/sndwaqwohx","doi":"https://doi.org/10.51847/sndwaqwohx","is_oa":true,"landing_page_url":"https://doi.org/10.51847/sndwaqwohx","pdf_url":"https://japer.in/storage/files/article/bf5eec66-9b52-4226-ad5d-0727ed9c875e-EKwthJgZBULa2DWr/2JCaOgfA1deHfOY.pdf","source":{"id":"https://openalex.org/S4210230375","display_name":"Journal Of Advanced Pharmacy Education And Research","issn_l":"2249-3379","issn":["2249-3379"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Advanced Pharmacy Education and Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://japer.in/storage/files/article/bf5eec66-9b52-4226-ad5d-0727ed9c875e-EKwthJgZBULa2DWr/2JCaOgfA1deHfOY.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018166810","display_name":"Ali Faris Hassan","orcid":"https://orcid.org/0009-0001-5650-1272","observed_orcids":["https://orcid.org/0009-0001-5650-1272"]},"institutions":[{"id":"https://openalex.org/I135120706","display_name":"University of Baghdad","ror":"https://ror.org/007f1da21","country_code":"IQ","type":"education","lineage":["https://openalex.org/I135120706"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Ali Faris Hassan","raw_affiliation_strings":["Department of Pharmacology and Toxicology , College of Pharmacy , University of Baghdad , Baghdad , Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology , College of Pharmacy , University of Baghdad , Baghdad , Iraq","institution_ids":["https://openalex.org/I135120706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009949656","display_name":"Maryam Rasheed Abd","orcid":"https://orcid.org/0000-0002-0811-9925","observed_orcids":["https://orcid.org/0000-0002-0811-9925"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Maryam Rasheed Abd","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063593426","display_name":"Shihab Hattab Mutlag","orcid":"https://orcid.org/0000-0002-5361-8221","observed_orcids":["https://orcid.org/0000-0002-5361-8221"]},"institutions":[{"id":"https://openalex.org/I135120706","display_name":"University of Baghdad","ror":"https://ror.org/007f1da21","country_code":"IQ","type":"education","lineage":["https://openalex.org/I135120706"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Shihab Hattab Mutlag","raw_affiliation_strings":["Department of Pharmacology and Toxicology , College of Pharmacy , University of Baghdad , Baghdad , Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology and Toxicology , College of Pharmacy , University of Baghdad , Baghdad , Iraq","institution_ids":["https://openalex.org/I135120706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022529136","display_name":"Sajida Hussein Ismail","orcid":"https://orcid.org/0000-0001-8490-8136","observed_orcids":["https://orcid.org/0000-0001-8490-8136"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sajida Hussein Ismael","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077977537","display_name":"Aisha Muthanna Shanshal","orcid":"https://orcid.org/0000-0002-9079-032X","observed_orcids":["https://orcid.org/0000-0002-9079-032X"]},"institutions":[{"id":"https://openalex.org/I56409017","display_name":"Nahrain University","ror":"https://ror.org/05v2p9075","country_code":"IQ","type":"education","lineage":["https://openalex.org/I56409017"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Aisha Muthanna Shanshal","raw_affiliation_strings":["Department of Clinical Pharmacy , College of Pharmacy , Al Nahrain University , Baghdad , Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy , College of Pharmacy , Al Nahrain University , Baghdad , Iraq","institution_ids":["https://openalex.org/I56409017"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108981754","display_name":"I. K. Jasim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801460691","display_name":"Al-Turath University","ror":"https://ror.org/019vd4365","country_code":"IQ","type":"education","lineage":["https://openalex.org/I2801460691"]}],"countries":["IQ"],"is_corresponding":false,"raw_author_name":"Ihsan Khudair Jasim","raw_affiliation_strings":["College of Pharmacy , Al-Turath University , Baghdad , Iraq"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Pharmacy , Al-Turath University , Baghdad , Iraq","institution_ids":["https://openalex.org/I2801460691"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5009949656"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7183,"has_fulltext":true,"cited_by_count":3,"citation_normalized_percentile":{"value":0.60531267,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"14","issue":"4","first_page":"41","last_page":"47"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.9854000210762024,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.009399999864399433,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11029","display_name":"Renal Diseases and Glomerulopathies","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fimasartan","display_name":"fimasartan","score":1.0},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.9480000138282776},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.9779999852180481},{"id":"https://openalex.org/keywords/renal-inflammation","display_name":"renal inflammation","score":0.9150000214576721},{"id":"https://openalex.org/keywords/angiotensin-receptor-blockers","display_name":"angiotensin receptor blockers","score":0.8790000081062317},{"id":"https://openalex.org/keywords/anti-inflammatory-activity","display_name":"anti-inflammatory activity","score":0.703000009059906},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.6620000004768372},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.4659999907016754}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7443253993988037},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.6212849020957947},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.570734441280365},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4443008005619049},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38682225346565247}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.51847/sndwaqwohx","doi":"https://doi.org/10.51847/sndwaqwohx","is_oa":true,"landing_page_url":"https://doi.org/10.51847/sndwaqwohx","pdf_url":"https://japer.in/storage/files/article/bf5eec66-9b52-4226-ad5d-0727ed9c875e-EKwthJgZBULa2DWr/2JCaOgfA1deHfOY.pdf","source":{"id":"https://openalex.org/S4210230375","display_name":"Journal Of Advanced Pharmacy Education And Research","issn_l":"2249-3379","issn":["2249-3379"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Advanced Pharmacy Education and Research","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.51847/sndwaqwohx","doi":"https://doi.org/10.51847/sndwaqwohx","is_oa":true,"landing_page_url":"https://doi.org/10.51847/sndwaqwohx","pdf_url":"https://japer.in/storage/files/article/bf5eec66-9b52-4226-ad5d-0727ed9c875e-EKwthJgZBULa2DWr/2JCaOgfA1deHfOY.pdf","source":{"id":"https://openalex.org/S4210230375","display_name":"Journal Of Advanced Pharmacy Education And Research","issn_l":"2249-3379","issn":["2249-3379"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Advanced Pharmacy Education and Research","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9763000011444092}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310603","display_name":"University of Baghdad","ror":"https://ror.org/007f1da21"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4403795186.pdf","grobid_xml":"https://content.openalex.org/works/W4403795186.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W2026849698","https://openalex.org/W2034121287","https://openalex.org/W2098919289","https://openalex.org/W2313124741","https://openalex.org/W2411630805","https://openalex.org/W2418696034","https://openalex.org/W2620760020","https://openalex.org/W2766619883","https://openalex.org/W2795801698","https://openalex.org/W2799934405","https://openalex.org/W2808332722","https://openalex.org/W2889351028","https://openalex.org/W2889546119","https://openalex.org/W2892580620","https://openalex.org/W2898919023","https://openalex.org/W2898924541","https://openalex.org/W2907921535","https://openalex.org/W2943696388","https://openalex.org/W2943810953","https://openalex.org/W2954015096","https://openalex.org/W2959356582","https://openalex.org/W2976591098","https://openalex.org/W2979968626","https://openalex.org/W2995555966","https://openalex.org/W2997317844","https://openalex.org/W2999974586","https://openalex.org/W3038022475","https://openalex.org/W4210242939","https://openalex.org/W4211121297","https://openalex.org/W4282550124","https://openalex.org/W4283771487","https://openalex.org/W4308322076","https://openalex.org/W4312982751","https://openalex.org/W4313120803","https://openalex.org/W4321087807","https://openalex.org/W4362584963","https://openalex.org/W4381469474","https://openalex.org/W4386331146"],"related_works":["https://openalex.org/W4282550124","https://openalex.org/W4394724887","https://openalex.org/W4396804135","https://openalex.org/W2413756404","https://openalex.org/W2900533507","https://openalex.org/W2063827687","https://openalex.org/W3181498203","https://openalex.org/W2108918698","https://openalex.org/W2898924541","https://openalex.org/W3037468784"],"abstract_inverted_index":{"The":[0,39],"nephrotoxicity":[1],"induced":[2],"by":[3],"methotrexate":[4,61],"is":[5,22],"a":[6,17,59],"severe":[7],"condition":[8],"that":[9,27],"greatly":[10],"affects":[11],"its":[12],"therapeutic":[13],"potential":[14,45],"and":[15,31],"has":[16],"significant":[18],"inflammatory":[19],"component.":[20],"Fimasartan":[21],"an":[23],"angiotensin":[24],"receptor":[25],"blocker":[26],"offers":[28],"organ-protective":[29],"effects":[30],"may":[32],"be":[33],"useful":[34],"in":[35],"mitigating":[36],"renal":[37],"injury.":[38],"present":[40],"study":[41],"explored":[42],"the":[43],"anti-inflammatory":[44],"of":[46,49],"two":[47],"doses":[48],"fimasartan":[50],"against":[51],"methotrexate-mediated":[52],"nephrotoxicity.":[53],"Albino":[54],"rats":[55],"were":[56],"intraperitoneally":[57],"administered":[58],"single":[60],"(20":[62],"mg/kg).":[63]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2024-10-27T00:00:00"}